A comprehensive view of men's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca Submits Patent Application for Methods of Treating Prostate Cancer
Published: July 15, 2024 by Medical Patent News
Merck and Orion exercise option granting Merck exclusive global rights to Opevesostat for prostate cancer; Merck to assume full development costs, Orion eligible for up to $1.63 billion in milestone payments
Published: July 01, 2024 by Merck & Co. Inc.
Janssen spearheads innovations in cancer with chemotherapy-free NSCLC regimen; company champions transgender-inclusive protocols in prostate cancer and presents new data on neurological disorders at EAN 2024
Published: June 29, 2024 by Industry Intelligence Inc.
US Patent Issued to Bristol-Myers Squibb on June 25 for "Methods of treating prostate cancer" (California Inventors)
Published: June 26, 2024 by U.S. Fed News
BioNTech and DualityBio receive FDA Fast Track designation for BNT324/DB-1311 in prostate cancer; third asset in collaboration to receive Fast Track, with 5-year survival rate of 36% for patients with metastatic CRPC.
Published: June 24, 2024 by BioNTech SE

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count